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Abstract 
Background: Interleukin-6 (IL-6) plays an important role in inflammatory. 
Epidural anesthesia is an appropriate method for controlling pain in lower 
limb surgeries. The aim of this study was to evaluate the effect of 
Dexmedetomidine and Lidocaine in the epidural injection by measuring IL-6 
plasma levels. 
Materials and Methods: Fifty-two patients with lower limb fractures in 
two groups receiving Dexmedetomidine doses and controls for the quality 
of epidural anesthesia and IL-6 index. After explaining the design and 
obtaining informed written consent, patients were randomly divided into 
two groups. After 4–6 minutes of administering the test dose, patients in 
group RC received 5 ml of 1.5% Lidocaine solution via epidural catheter. 
Patients in group RD were administered 15 ml solution of 1.5% ropivacaine 
and 0.6 μg/kg of Dexmedetomidine. The levels of IL-6 were evaluated 
before surgery and 6 hours after surgery. 
Results: The two groups did not show a significant difference in age and 
level of interleukin prior to the operation. There was a significant difference 
in the second injection time and total drug volume between the control and 
intervention groups. Dexmedetomidine reduced the volume of total drug 
needed and increased the time interval from the first injection to the second 
one (p <0.001).There was also lower levels of interleukin 6 in the 
Dexmedetomidine group at the 6th hour after the operation.  
Conclusion: Dexmedetomidine does not only reduce the need for patients on 
the amount and frequency of analgesic drugs, but also reduces stress and 
cellular damage. 
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Introduction 
The increasing use of topical anesthetic, major 
and minor neural blocks has led to the selective use of 
general anesthesia. This is because avoiding general 
anesthesia risks, better postoperative pain control, and 
some other factors in long-term surgery and long-term 
postoperative pain control, local anesthetic drugs with 
a long-lasting effect are common. Meanwhile, 
auxiliary drugs are also used to maximize the length 
of the base drug (1). 
Considering the history of local anesthesia and 
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many studies in this field, today, the tendency of 
anesthesiologists to perform local block has increased 
and this may reduce the need for general anesthesia 
(1). This method is used to carry out surgical 
procedures or control postoperative pain in order to 
remove pain and to create anesthesia (2), creating 
favorable conditions during surgery and faster 
postoperative patient mobility, and decreasing the 
risks of general anesthesia and hospital costs (3). 
Lidocaine reduces inflammatory processes. 
The substance acts by lowers the release of cytokines 
from epithelial cells and neutrophils and reducing the 
production of cytokines caused by damage to 
endothelial cells (4). These cytokines are of the pro-
inflammatory type (5). 
Dexmedetomidine is an α-agonist (11). Some 
studies have shown that the use of this drug (due to its 
low toxicity) can reduce cell death. (6). This drug 
lowers the concentration of tumor necrosis alpha 
(TNF-α) (7,8). On the other hand, in various studies 
on apoptosis of the epithelial cells of the intestine, it 
has reduced the inflammatory response and 
accelerated the intestinal improvement after trauma 
(9,10). In several studies, the positive effect of 
intravenous Dexmedetomidine on the control of 
inflammatory responses and the reduction of levels of 
inflammatory mediators such as IL-6 has been 
confirmed (12-15). 
The purpose of this study was to learn whether 
the use of this drug as an adjuvant in epidural 
injection has meaningful effects. Confirmation of this 
positive effect can provide a low cost and easy 
method to reduce the complications of inflammatory 
response after lower limb surgery. 
Methods 
In this study, all patients were referred to 
Taleghani Hospital (affiliated to Shahid Beheshti 
University of Medical Sciences, Tehran, Iran) in 
2017, who suffered from lower limb fractures and 
who needed surgery were evaluated. The inclusion 
criteria were: 18-75 years old, lower limb fractures, 
ASA Class I & II, and no history of allergy. However, 
the following patients were not included in the study: 
absolute contraindication for using local anesthetics, 
and the presence of these comorbidities: diabetes 
mellitus, myocardial infarction, major cardiovascular 
events, cerebrovascular accidents, hypertension, 
malignancy, renal failure, liver dysfunction and 
coagulation disorders.  
After explaining the design and obtaining 
informed written consent, patients were randomly 
divided into two groups. Patients were administered 
epidural block with 18-gauge Tuohy needle and 
catheter was secured 3–4 cm into epidural space and a 
test dose of 3 ml of 2% Lidocaine solution containing 
adrenaline 1:200,000 was injected. After 4–6 minutes 
of administering the test dose, patients in group RC 
received 5 ml of 1.5% Lidocaine solution. Patients in 
group RD were administered 15 ml solution of 1.5% 
ropivacaine and 0.6 μg/kg of Dexmedetomidine. The 
bilateral pin-prick method was used to evaluate and 
check the sensory level while a modified Bromage 
scale (0 = no block, 1 = inability to raise extended leg, 
2 = inability to flex knee and 3 = inability to flex 
ankle and foot) was used to measure the motor 
blockade effect at 5, 10, 15, 20, 25 and 30 minutes 
intervals after the epidural administration of the 
drugs. 
The second dose was injected every 45-60 
minutes based on need (VAS> 3; Visual Analog 
Scale: VAS), then 8 mL of 1.5%, Lidocaine and the 
final dose of the received drug was recorded at the 
end of the operation. Blood samples were taken from 
all patients before entering the operating room to 
determine the level of the interleukin-6. During 
surgery, the onset of anesthesia, time to second 
injection, duration of operation and volume of blood 
loss, the volume of intake and output, and the amount 
of injected drug by the epidural catheter were 
recorded. In order to control the pain in all patients, 
intravenous morphine infusion pump was given at a 
dose of 3 to 5 mg/hr. Additional drug doses were 
prescribed if necessary to maintain VAS <3 in the 
first 24 hours. Blood samples were taken at 6 hours 
after surgery to measure the level of interleukin-6 in 
all patients. 
IL-6 detection method 
5 cc blood samples were taken from the patient 
and placed in a simple test tube. After blood clotting 
at room temperature (15-30 minutes), it was 
centrifuged (3000 to 3500) at room temperature for 15 
minutes. The yielding plasma was poured into the 
microtube and stored in -70˚C. Collected samples 
evaluated by Bio-Science ELISA Kits. 
The obtained data was collected and using 
descriptive statistics, the results of IL-6 were reported 
according to the variables in question. In addition, to 
compare the IL-6 level among the patients in both 
groups, independent t-test was used. 
Results 
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In this study, 52 patients, 19 women (36.5%) 
and 33 men (63.5%), were divided into two groups of 
26 patients. The mean age of the patients was 
15.8±53.4 years (Table 1). 
Based on the results, the mean of the second 
injection requirement (51 out of 52) was 60.7 ± 21.7. 
Duration of surgery was same between the two 
groups. Also no significant difference in volume of 
received fluid during surgery and the level of baseline 
interleukin was seen. On the other hand, based on 
independent t-test, there was a significant difference 
between the two groups regarding the bleeding and 
urine volumes (p <0.05) (Table 2).According to the U 
Mann Whitney test, the second injection and drug 
levels were significantly different between the control 
and intervention groups. Dexmedetomidine reduced 
the need for a second injection (p <0.001) (Table 3). 
There was a significant difference between the 
two groups in terms of IL-6 after 6 hours of operation, 
and this was lower in the Dexmedetomidine group 
(Table 4). 
Discussion 
Today, use of regional anesthesia is superior to 
general anesthesia in many procedures, because it has 
fewer side effects and makes it easier for the patient 
to have mobility and daily activities. In recent years, 
however, stress and cellular damage have become a 
problem that attracts the attention of experts and 
researchers and has attracted efforts to reduce it. This 
study also considers the importance of the present 
method using two different drugs. 
Lidocaine and relevant drugs, which are used 
primarily as positional anesthetics and antiarrhythmic 
factors. Lidocaine exerts immunoregulatory effects on 
a variety of cell types. For example, lidocaine-related 
local anesthetics were shown to inhibit lymphocyte 
maturation and proliferation, the migration of 
macrophages into tissues (16), the expression of 
CD11b/CD18 by polymorphonuclear cells (19), the 
adhesion of leucocytes to injured venules (17–19) and 
the LPS-stimulated secretion of LTB4 and IL-1a from 
peripheral blood mononuclear cells (20). Moreover, 
the anti-inflammatory effects of lidocaine were shown 
by in vivo studies as well. Taniguchi  et al., have 
shown that lidocaine treatment of rabbits injected 
with endotoxin reduced the serum concentrations of 
IL-8 and IL-6 (21). 
Previous studies have shown DEX has a low 
cytotoxic effect, which in some studies reduces cell 
death (6). On the other hand, this drug lowers the 
concentration of tumor necrosis alpha (TNF-α) (7,8). 
In various studies on apoptosis of the epithelial cells 
of the intestine, it reduces the inflammatory response 
and accelerates the intestinal improvement after 
trauma (9,10). In several studies, the positive effect of 
intravenous Dexmedetomidine on the control of 
inflammatory responses and the decrease, of levels of 
inflammatory mediators such as IL-6 has been 
confirmed (12-15). 
Accordingly, based on these results, 
dexmedetomidine not only reduces the amount and 
frequency of analgesic drug administration, but also 
reduces stress and cellular damage. So, 
dexmedetomidine is suggested as a good option for 
Table 1: Descriptive statistics of variables 
 N Minimum Maximum Mean Std. Deviation 
Age (years) 52 24.00 75.00 53.4038 15.8439 
Onset time (min) 52 10.00 22.00 15.8846 3.12268 
Second 
injection(min) 
51 35.00 165.00 60.7647 21.71690 
LA Final Vol (ml) 52 20.00 65.00 42.0385 9.48469 
Received fluid (L) 52 1.50 28.00 3.0808 3.55500 
Blooding volume 
(ml) 
52 50.00 600.00 257.3077 122.60434 
Urine volume (ml) 52 50.00 1000.00 595.1923 173.56120 
Base Serum IL 
(pg/ml) 
52 0.20 23.50 4.1892 5.70042 
Six hours IL_6 
(pg/ml) 
52 1.1 120 20.07 19.93 
Surgery time (min) 52 75.00 300.00 177.2115 43.81796 
Valid Number of 
cases 
51     
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similar surgeries. Of course, further studies are 
needed in order to evaluate the best application and 
other effects of the drugs used in this study can lead 
to better anesthesia plans. 
 
Conclusion 
Not only does dexmedetomidine reduce the 
need for patients on the amount and frequency of 
analgesic drugs, but also it lowers stress and cellular 
damage. 
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Table 2- Based on independent t-test, among the variables studied in this study, the mean volume of bleeding and volume of 
urine show a significant difference between the control and intervention groups. 
 Leven,s Test 
for Equality of 
Variances 
 
t-test for Equality of Means 






95% Confidence interval 







0.205 0.653 3.315 50 0.02 103.07692 31.09539 40.62000 165.53385 
Equal variances 
not assumed 






2.370 0.130 2.472 50 0.017 113.46154 45.89188 21.28498 205.63810 
Equal variances 
not assumed 






1.405 0.241 0.424 50 0.674 5.19231 12.25186 -19.41627 29.80089 
Equal variances 
not assumed 
  0.424 46.215 0.674 5.19231 12.25186 -19.46630 29.85092 
 
 
Table 3- According to the U Mann Whitney test, the second injection and drug levels had a significant difference between the 
control and intervention groups 




Normal saline 26 14.00 364.00 
Dexmedetomidine 26 39.00 1014.00 




Normal saline 26 18.58 483.00 
Dexmedetomidine 25 33.72 843.00 




Normal saline 26 27.71 720.50 
Dexmedetomidine 26 25.29 657.50 
Total 52   
 
 
Base serum IL-6 level 
Normal saline 26 26.15 680.00 
Dexmedetomidine 26 26.85 698.00 
Total 52   
 
 
Table 4: The mean level of interleukin six hours after surgery, which was the main presumption in this study, is also p <0.05, 
which shows a significant difference between the two groups. 
 
Group N Mean Std. Deviation Std. Error Mean 
Six hours IL-6 
level 
Normal saline 27 26.6333 24.44054 4.70358 
Dexmedetomidine 25 12.9800 9.81411 1.96282 
 
